v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 26, 2026
Sep. 27, 2025
Operating activities:    
Net income $ 38,539 $ 10,672
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 58,274 65,976
Depreciation and amortization 13,247 13,310
Deferred income taxes 9,361 8,778
Net accretion of available-for-sale securities (906) (3,001)
Changes in operating assets and liabilities:    
Accounts receivable, net (28,115) (8,144)
Inventory (54,128) (5,255)
Prepaid expenses and other assets (22,659) 11,297
Accounts payable 21,107 (71)
Accrued liabilities 1,698 (5,936)
Deferred revenue (271) (3,702)
Other long-term liabilities 1,301 4,983
Net cash provided by operating activities 37,448 88,907
Investing activities    
Purchases of property and equipment (15,572) (13,670)
Purchases of marketable securities (31,749) (166,936)
Sales of marketable securities 81,314 11,362
Maturities of marketable securities 96,301 168,350
Net cash provided by (used in) investing activities 130,294 (894)
Financing activities:    
Proceeds from common stock issuances related to employee benefit plans 35,302 40,821
Repurchases of common stock (290,227) (77,010)
Net cash used in financing activities (254,925) (36,189)
Effect of exchange rate changes on cash and cash equivalents (13) 26
Net increase (decrease) in cash and cash equivalents (87,196) 51,850
Cash and cash equivalents at beginning of period 143,086 43,162
Cash and cash equivalents at end of period $ 55,890 $ 95,012

Source